Report Details
Introduction
- Strong Market Growth Forecast: The Europe glucose monitoring devices market is poised for substantial growth, with its valuation expected to rise from approximately USD 8.15 billion in 2024 to over USD 18.40 billion by 2032, signaling a significant increase in regional demand.
- Double-Digit CAGR Momentum: Expanding at a CAGR of nearly 10.6% during the forecast period, this growth is fueled by rising diabetes prevalence, increased adoption of digital health technologies, and consumer preference for continuous glucose monitoring systems.
- Technological Advancements Driving Adoption: Innovations in wearable glucose monitors, growing awareness around early diabetes management, and supportive healthcare reimbursement policies are accelerating the market expansion across major European economies.
Ansoff Matrix – Europe Glucose Monitoring Devices Market
- Market Penetration: Strengthen market share by offering subscription-based pricing models for continuous glucose monitors (CGMs). Expand direct-to-consumer channels and pharmacy-based sales across Western and Central Europe. Increase awareness campaigns around diabetes management through collaborations with healthcare providers. Leverage user-friendly mobile integrations and apps to retain and attract tech-savvy consumers.
- Market Development: Enter untapped or underserved regions such as Eastern Europe and rural healthcare markets. Partner with government health programs and NGOs to improve access to glucose monitoring in lower-income populations. Customize language support and device interfaces for localized user experiences. Target non-traditional distribution points, including e-commerce platforms and telehealth services.
- Product Development: Invest in next-gen CGMs with non-invasive or needle-free technology. Integrate AI-driven analytics for predictive glucose trends and real-time feedback. Develop multi-functional wearables that combine glucose tracking with other vital health indicators. Offer compact, rechargeable, and environmentally sustainable monitoring devices.
- Diversification: Explore adjacent markets such as digital diabetes coaching, diet tracking apps, and insulin delivery systems. Develop bundled solutions combining glucose monitoring with remote patient monitoring platforms. Collaborate with fitness and wellness brands to promote preventive health management for prediabetic consumers. Invest in R&D to expand into biosensor-based health diagnostics beyond glucose monitoring.
Navigating Market Segments: Europe Glucose Monitoring Devices
1. By Product Type
1.1 Self-Monitoring Blood Glucose (SMBG) Devices
1.2 Continuous Glucose Monitoring (CGM) Devices
1.3 Flash Glucose Monitoring (FGM) Devices
2. By Component
2.1 Glucose Meters
2.2 Testing Strips
2.3 Lancets
2.4 Sensors
2.5 Transmitters & Receivers
2.6 Insulin Pumps
2.7 Others
3. By End User
3.1 Hospitals & Clinics
3.2 Homecare Settings
3.3 Diagnostic Centers
3.4 Others
4. By Distribution Channel
4.1 Retail Pharmacies
4.2 Online Pharmacies
4.3 Hospital Pharmacies
5. By Region – Global Glucose Monitoring Devices Market
5.1 North America
5.1.1 United States
5.1.2 Canada
5.2 Europe
5.2.1 United Kingdom
5.2.2 Germany
5.2.3 France
5.2.4 Italy
5.2.5 Spain
5.2.6 Rest of Europe
5.3 Asia-Pacific
5.3.1 China
5.3.2 India
5.3.3 Japan
5.3.4 South Korea
5.3.5 Australia
5.3.6 Rest of Asia-Pacific
5.4 Latin America
5.4.1 Brazil
5.4.2 Mexico
5.4.3 Rest of Latin America
5.5 Middle East and Africa
5.5.1 United Arab Emirates
5.5.2 Saudi Arabia
5.5.3 South Africa
5.5.4 Egypt
5.5.5 Rest of Middle East and Africa
6. Key Players – Europe Glucose Monitoring Devices Market
6.1 Abbott Laboratories
6.2 F. Hoffmann-La Roche Ltd
6.3 Dexcom, Inc.
6.4 Medtronic plc
6.5 Ascensia Diabetes Care (a PHC Holdings Corporation company)
6.6 Senseonics Holdings, Inc.
6.7 LifeScan, Inc.
6.8 Ypsomed Holding AG
6.9 Menarini Diagnostics
6.10 Bionime Corporation
6.11 Nova Biomedical
6.12 Acon Laboratories, Inc.
6.13 Sanofi (for digital diabetes care partnerships)
6.14 Terumo Europe NV
6.15 Others
Table of Contents (TOC)
1. Introduction
1.1. Study Objectives
1.2. Report Description
1.3. Market Definition & Scope
1.4. Methodology
1.5. Research Assumptions
2. Executive Summary
2.1. Market Overview
2.2. Key Highlights
2.3. Europe Snapshot
2.4. Key Opportunities
3. Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
3.4. Technological Trends
3.5. Regulatory Landscape
4. Market Outlook – Europe Glucose Monitoring Devices Market
4.1. Market Size and Forecast (2024–2032)
4.2. Market Trends and Developments
4.3. Pricing Analysis
4.4. Value Chain Analysis
4.5. Supply Chain Overview
5. Impact Analysis
5.1. COVID-19 Impact Assessment
5.2. Emerging Technologies Impact
5.3. Geopolitical and Economic Impact
6. Market Segmentation Analysis
6.1. By Product Type
6.1.1. Self-Monitoring Blood Glucose (SMBG) Devices
6.1.2. Continuous Glucose Monitoring (CGM) Devices
6.1.3. Flash Glucose Monitoring (FGM) Devices
6.2. By Component
6.2.1. Glucose Meters
6.2.2. Testing Strips
6.2.3. Lancets
6.2.4. Sensors
6.2.5. Transmitters & Receivers
6.2.6. Insulin Pumps
6.2.7. Others
6.3. By End User
6.3.1. Hospitals & Clinics
6.3.2. Homecare Settings
6.3.3. Diagnostic Centers
6.3.4. Others
6.4. By Distribution Channel
6.4.1. Retail Pharmacies
6.4.2. Online Pharmacies
6.4.3. Hospital Pharmacies
7. Global Glucose Monitoring Devices Market – Regional Analysis
7.1. North America
7.1.1. United States
7.1.2. Canada
7.2. Europe
7.2.1. United Kingdom
7.2.2. Germany
7.2.3. France
7.2.4. Italy
7.2.5. Spain
7.2.6. Rest of Europe
7.3. Asia-Pacific
7.3.1. China
7.3.2. India
7.3.3. Japan
7.3.4. South Korea
7.3.5. Australia
7.3.6. Rest of Asia-Pacific
7.4. Latin America
7.4.1. Brazil
7.4.2. Mexico
7.4.3. Rest of Latin America
7.5. Middle East and Africa
7.5.1. United Arab Emirates
7.5.2. Saudi Arabia
7.5.3. South Africa
7.5.4. Egypt
7.5.5. Rest of Middle East and Africa
8. Competitive Landscape – Europe Glucose Monitoring Devices Market
8.1. Market Share Analysis
8.2. Key Strategic Initiatives
8.3. Product Innovation & R&D
9. Key Players – Europe Glucose Monitoring Devices Market
9.1. Abbott Laboratories
9.2. F. Hoffmann-La Roche Ltd
9.3. Dexcom, Inc.
9.4. Medtronic plc
9.5. Ascensia Diabetes Care (a PHC Holdings Corporation company)
9.6. Senseonics Holdings, Inc.
9.7. LifeScan, Inc.
9.8. Ypsomed Holding AG
9.9. Menarini Diagnostics
9.10. Bionime Corporation
9.11. Nova Biomedical
9.12. Acon Laboratories, Inc.
9.13. Sanofi (for digital diabetes care partnerships)
9.14. Terumo Europe NV
10. Strategic Recommendations
11. Appendix
12. Glossary of Terms
13. Contact & Research Support
Navigating Market Segments: Europe Glucose Monitoring Devices
1. By Product Type
1.1 Self-Monitoring Blood Glucose (SMBG) Devices
1.2 Continuous Glucose Monitoring (CGM) Devices
1.3 Flash Glucose Monitoring (FGM) Devices
2. By Component
2.1 Glucose Meters
2.2 Testing Strips
2.3 Lancets
2.4 Sensors
2.5 Transmitters & Receivers
2.6 Insulin Pumps
2.7 Others
3. By End User
3.1 Hospitals & Clinics
3.2 Homecare Settings
3.3 Diagnostic Centers
3.4 Others
4. By Distribution Channel
4.1 Retail Pharmacies
4.2 Online Pharmacies
4.3 Hospital Pharmacies
5. By Region – Global Glucose Monitoring Devices Market
5.1 North America
5.1.1 United States
5.1.2 Canada
5.2 Europe
5.2.1 United Kingdom
5.2.2 Germany
5.2.3 France
5.2.4 Italy
5.2.5 Spain
5.2.6 Rest of Europe
5.3 Asia-Pacific
5.3.1 China
5.3.2 India
5.3.3 Japan
5.3.4 South Korea
5.3.5 Australia
5.3.6 Rest of Asia-Pacific
5.4 Latin America
5.4.1 Brazil
5.4.2 Mexico
5.4.3 Rest of Latin America
5.5 Middle East and Africa
5.5.1 United Arab Emirates
5.5.2 Saudi Arabia
5.5.3 South Africa
5.5.4 Egypt
5.5.5 Rest of Middle East and Africa
6. Key Players – Europe Glucose Monitoring Devices Market
6.1 Abbott Laboratories
6.2 F. Hoffmann-La Roche Ltd
6.3 Dexcom, Inc.
6.4 Medtronic plc
6.5 Ascensia Diabetes Care (a PHC Holdings Corporation company)
6.6 Senseonics Holdings, Inc.
6.7 LifeScan, Inc.
6.8 Ypsomed Holding AG
6.9 Menarini Diagnostics
6.10 Bionime Corporation
6.11 Nova Biomedical
6.12 Acon Laboratories, Inc.
6.13 Sanofi (for digital diabetes care partnerships)
6.14 Terumo Europe NV
6.15 Others
Download Sample Request Form
Make an Inquiry
Ask for Discount
Frequently Asked Questions
Why is Europe becoming a global leader in smart glucose monitoring in 2025?
Driven by skyrocketing diabetes rates, digital health innovation, and strict EU healthcare policies, Europe is emerging as a hub for cutting-edge glucose monitoring devices. Countries like Germany, the UK, and the Netherlands are embracing AI-driven wearables and non-invasive sensors at record speed.
What’s replacing finger-prick testing in Europe’s glucose monitoring space?
Continuous Glucose Monitoring (CGM) systems and Flash Glucose Monitoring (FGM) are transforming diabetes care. With real-time tracking, Bluetooth integration, and app-based alerts, these devices are quickly becoming the standard across clinics and home settings alike.
Which European nations are accelerating the adoption of next-gen glucose monitors?
Germany, France, the UK, and the Nordics lead the charge thanks to favorable reimbursement policies, tech-savvy populations, and robust telehealth networks. Southern and Eastern Europe are catching up fast due to EU funding and growing chronic care demand.
How is wearable tech reshaping the glucose monitoring market in Europe?
Smartwatches, skin patches, and AI-enhanced biosensors are redefining patient lifestyles. These discreet, wearable glucose monitors offer not just glucose data—but also insights on diet, sleep, and activity—blending chronic care with wellness in a uniquely European model.
Are European startups shaking up the glucose monitoring device industry?
Absolutely. Startups across Berlin, Stockholm, and Barcelona are pioneering needle-free monitoring, real-time cloud syncing, and subscription-based glucose tech—making diabetes management not only smarter but also more affordable and user-friendly for millions across the continent.